ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2012 ACR/ARHP Annual Meeting

November 9-14, 2012 in Washington, DC

View by Title View Sessions
Jump to:  View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1757
    B Cell Activating Factor Receptor Expression After Rituximab: Comparison of Patients with Rheumatoid Arthritis and Thrombotic Thrombocytopenic Purpura
  • Abstract Number: 1764
    B Cells in Early Rheumatoid Arthritis: ZAP-70 More Than SYK Characterize Seropositive Disease
  • Abstract Number: 610
    B Lymphocyte Stimulator Levels Are Higher in Caucasian SLE Patients Earlier in Disease Course and Predict Damage Accumulation
  • Abstract Number: 482
    B-Lymphocyte Count Is Not Associated with an Increased Risk of Infection in Patients Treated with Rituximab for Auto-Immune Diseases
  • Abstract Number: 618
    BAFF/BLyS Gene Expression Predicts Disease Activity in Systemic Lupus Erythematosis Over One Year
  • Abstract Number: 2429
    Balancing Work and Health: Do Younger Workers Experience More Work-Health Conflict Than Middle- and Older-Aged Workers with Rheumatic Diseases?
  • Abstract Number: 1577
    Barriers to Recruit Unaffected Family Members of  Patients with Rheumatoid Arthritis
  • Abstract Number: 1234
    Barriers, Benefits and Preferences for Exercise in RA Patients: A Cross Sectional Study
  • Abstract Number: 398
    Basal Metabolic Rate As an Indicator of Rheumatoid Arthritis Disease Activity and Predictor of Remission
  • Abstract Number: 1237
    Baseline Evaluation of Insulin Resistance in Patients with early Non-Treated Rheumatoid Arthritis
  • Abstract Number: 2158
    Baseline Folate Related Biomarkers in Serum and erythrocytes Are Not Associated with Methotrexate Response and Adverse Events in Rheumatoid Arthritis
  • Abstract Number: 1107
    Baseline Knee Flexion Pain, Age and Joint Line Tenderness Predict the Progression of Asymptomatic, Radiographic Knee Osteoarthritis to Symptomatic Knee Osteoarthritis Over 5 Years
  • Abstract Number: 615
    Baseline Laboratory Characteristics From the Combined Placebo Groups in the Phase 3 Belimumab Trials Are Predictive of Severe Flare At 52 Weeks
  • Abstract Number: 1573
    Baseline Screening Recommendations for Rheumatoid Arthritis Patients Treated with Disease Modifying Anti-Rheumatic Drugs:  Does an Educational Intervention Change Practice in an Outpatient Clinic?
  • Abstract Number: 431
    Basic and Clinical Significance of Interleukin 6 (IL-6) in AA Amyloidosis with RA
  • Abstract Number: 601
    Bath Ankylosing Spondylitis Functional Index (BASFI) Is a Better Indicator of Poor Quality of Life Than Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in Ankylosing Spondylitis: Results From SIRAS – the Scotland and Ireland Registry for Ankylosing Spondylitis
  • Abstract Number: 2376
    Behcet’s Disease: Combination of Pulse Cyclophosphamide, Azathioprine, and Prednisolone for the Treatment of Retinal Vasculitis; Longitudinal Study On 10 Years
  • Abstract Number: 1341
    Beneficial Effect of Anti-TNF Therapy in the Lipoprotein Atherogenic Risk Profile in Comparison with DMARD Standard Therapy in RA Patients
  • Abstract Number: 757
    Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
  • Abstract Number: 2652
    Benefits of Aerobic Training in Patients with Ankylosing Spondylitis Are Not Coupled by Effects On Cytokines: A Randomized Controlled Trial
  • Abstract Number: 2695
    Benefits of the Chronic Disease Self-Management Program in Low-Income African American Women with Systemic Lupus Erythematosus:  Results of a Pilot Test
  • Abstract Number: 84
    Benefits of Treat-to-Target Guideline Compliance in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis
  • Abstract Number: 1562
    Benign Joint Hypermobility Syndrome More Common Than Expected,Both in Controls and in SLE Patients
  • Abstract Number: 458
    Better Retention RATE At 5 YEARS of ANTI-TNF Agents USED in Conjonction with Methotrexate Over Time in Patients with Rheumatoid Arthritis: REAL-Life DATA From Rhumadata Computarized Database
  • Abstract Number: 616
    Bioavailability, Pharmacokinetics, and Safety of Belimumab Administered Subcutaneously in Healthy Subjects
  • Abstract Number: 457
    Biologic Disease-Modifying Anti-Rheumatic Drugs and the Risk of Non-Vertebral Osteoporotic Fractures in Patients with Rheumatoid Arthritis Aged 50 Years and Over
  • Abstract Number: 2638
    Biologic Switching Among Patients with Rheumatoid Arthritis in the United States, 2004-2011
  • Abstract Number: 1801
    Biological Roles of C5orf30 in Rheumatoid Arthritis
  • Abstract Number: 1642
    Biologics and Mortality Risk in Rheumatoid Arthritis – Results of a Population Based Study
  • Abstract Number: 1923
    Biologics in Relapsing Polychondritis: A Single Center Case-Series
  • Abstract Number: 1709
    Biomarkers of Atherosclerosis Are Associated with Progression of Non-Cardiovascular Damage in Patients with SLE
  • Abstract Number: 2498
    Biomarkers of Mitochondrial Dysfunction Correlate with Disease Activity in SLE
  • Abstract Number: 719
    Biomarkers of Pulmonary Hypertension in Patients with Scleroderma: A Case-Control Study
  • Abstract Number: 790
    Biomechanical Function Agrees with Clinical Implications of  Foot Disorders in a Population-Based Study
  • Abstract Number: 1512
    Bleomycin Delivery by Osmotic Pump: A Superior Model for Human ILD
  • Abstract Number: L6
    Blisibimod, an Inhibitor of B Cell Activating Factor, in Patients with Moderate-to-Severe Systemic Lupus Erythematosus
  • Abstract Number: 332
    Blockade of CTGF Restores Aberrant Ostoclastgenesis in Collagen Induced Arthritis (CIA) Mice Through Inhibition of Th-17 Differentiation
  • Abstract Number: 2681
    Blocking the Serum Protease Inhibitor Activity of Plasminogen Activator Inhibitor-1 Protects Mice From Development of Glomerulonephritis in a Model of Lupus Nephritis
  • Abstract Number: 2392
    Blood Vessel Instability and Oxidative Damage in Giant Cell Arteritis
  • Abstract Number: 312
    Blood-Based Biomarkers of Neurocognitive Dysfunction in Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 800
    BMI, Occupational Activity, and Leisure-Time Physical Activity: an Exploration of Risk Factors and Modifiers for Knee Osteoarthritis
  • Abstract Number: 2395
    Body Composition, Strength, and Function in Elderly Patients with Giant Cell Arteritis
  • Abstract Number: 478
    Body Mass Index Negatively Influences the Response to Infliximab in Rheumatoid Arthritis
  • Abstract Number: 2582
    Bone Anabolic Changes Progress in Psa Patients Despite Treatment with Methotrexate or Tumour Necrosis Factor Inhibitors
  • Abstract Number: 2072
    Bone Formation and Resorption Are Both Increased in Autoimmune Arthritis
  • Abstract Number: 1010
    Bone Loss Before Clinical Onset of Rheumatoid Arthritis o Subjects with Anti-Citrullinated Protein Antibodies
  • Abstract Number: 271
    Bone Marrow Lesions in Knees with Osteoarthritis: Can Parameters From Dynamic Contrast Enhancement Predict Change in Bone Marrow Lesion Volume or Knee Pain Change?
  • Abstract Number: 38
    Bone Marrow Lesions On Magnetic Resonance Imaging Are Not Associated with Regions of Hypermetabolism in an Animal Model of Osteoarthritis
  • Abstract Number: 1958
    Bone Mineral Density in Lupus Erythematosus Women One Year After Rituximab Therapy
  • Abstract Number: 2583
    Bone Structure and Perfusion Quantification of Bone Marrow Edema and Pannus Tissue Areas in the Wrist of Patients with RA
  • Abstract Number: 125
    Borderline Right Ventricular Involvement in Patients with Systemic Sclerosis without Pulmonary Hypertension
  • Abstract Number: 295
    Brain Biopsy Diagnosis in Magnetic Resonance Imaging Negative Childhood Primary Angiitis of the Central Nervous System
  • Abstract Number: 587
    Brain MRI and Psychophysics Analysis Demonstrate Neuropathic Pain to Be a Component of Back Pain in Ankylosing Spondylitis
  • Abstract Number: 2525
    Bruton’s Tyrosine Kinase Inhibition Suppresses Inflammatory Cytokine Production and Affects Gene Expression in Human Macrophages and RA Synovial Tissue Explants
  • Abstract Number: 2526
    Bruton′s Tyrosine Kinase and Calreticulin: A Novel Interaction with Implications for Inflammatory and Autoimmune Disease
  • Abstract Number: 1856
    Burden of Adverse Events Associated with Immunosuppressant Therapy for the Treatment of Systemic Lupus Erythematosus: A Systematic Literature Review
  • Abstract Number: 304
    Burden of Childhood Central Nervous System Vasculitis: Identifying High Risk Factors for Poor Cognitive Outcome
  • Abstract Number: 1017
    Bye Bye Biopsy: Diffusion Tensor and Dynamic Contrast Enhance Magnetic Resonance Imaging Parameters Reflect Molecular Events of Inflammation in the Synovium
Jump to:  View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.